FineImmune Biotechnology

Solving technical bottlenecks in tumor microenvironment

Category
Gene and Cell Therapy
Location
China
Website
Visit website

About the company

T cell therapy company focusing on solving technical bottlenecks in the TME and has discovered a number of proprietary biomarkers which could be used as targets, such as CXCL13, for anti-cancer cell therapies, including TAL, personalized TCRT and CART